Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Top Ten Holdings Of Theo Kolokotrones

Published 05/18/2022, 01:43 AM

Theo A. Kolokotrones is the Chairman, Director and Portfolio Manager at Primecap Management Company which he co-founded in September 1983. From 1970 to 1977, he worked as Vice President and Senior Financial Analyst at Smith Barney, Harris Upham and Company in New York, and for six years at Capital Research Company. Kolokotrones is a graduate of the University of Chicago and the Harvard Graduate School of Business Administration.

Top Ten Holdings

We have referred to the latest 13F filing (March 31, 2022) of Primecap Management Company to come up with the top ten holdings of Theo Kolokotrones. Following are the top ten holdings of Theo Kolokotrones:

10. FedEx

Founded in 1971 and headquartered in Memphis, Tenn., FedEx (NYSE:FDX) supports transportation, e-commerce, and business services. Kolokotrones owns over 13 million shares of FedEx Corporation at an estimated average price of $68.21. These shares have a market value of more than $3 billion and account for 2.31% of Kolokotrones’ portfolio. Kolokotrones has owned FedEx shares since Q1 2001 and has recently bought some more shares of it.

9. AstraZeneca

Founded in 1992 and headquartered in Cambridge, UK, AstraZeneca (NASDAQ:AZN) researches and develops pharmaceutical products. Kolokotrones owns over 46 million shares of AstraZeneca at an estimated average price of $32.01. These shares have a market value of more than $3 billion and account for 2.32% of Kolokotrones’ portfolio. Kolokotrones has owned AstraZeneca shares since Q3 2015 and has recently sold some shares of it.

8. Alphabet

Founded in 2015 and headquartered in Mountain View, Calif., Alphabet (NASDAQ:GOOG) is a holding company that operates through Google (NASDAQ:GOOGL) and Other Bets segments. Kolokotrones owns over 1.1 million shares of Alphabet at an estimated average price of $596.02. These shares have a market value of more than $3 billion and account for 2.32% of Kolokotrones’ portfolio. Kolokotrones has owned Alphabet shares since Q2 2014 and has recently sold some shares of it.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

7. Micron Technology

Founded in 1978 and headquartered in Boise, Idaho, Micron (NASDAQ:MU) offers innovative memory and storage solutions. Kolokotrones owns over 40 million shares of Micron at an estimated average price of $18.37. These shares have a market value of more than $3.1 billion and account for 2.40% of Kolokotrones’ portfolio. Kolokotrones has owned Micron Technology shares since Q1 2001 and has recently sold some shares of it.

6. Texas Instruments

Founded in 1930 and headquartered in Dallas, Texas Instruments (NASDAQ:TXN) deals in analog and embedded semiconductors. Kolokotrones owns over 17 million shares of Texas Instruments at an estimated average price of $29.20. These shares have a market value of more than $3.2 billion and account for 2.45% of Kolokotrones’ portfolio. Kolokotrones has owned Texas Instruments shares since Q1 2001 and has recently sold some shares of it.

5. Biogen

Founded in 1978 and headquartered in Cambridge, Mass., Biogen (NASDAQ:BIIB) is a biopharmaceutical company that develops therapies for neurological and neurodegenerative diseases. Kolokotrones owns over 15 million shares of Biogen at an estimated average price of $84.58. These shares have a market value of more than $3.3 billion and account for 2.52% of Kolokotrones’ portfolio. Kolokotrones has owned Biogen shares since Q2 2003 and has recently bought some shares of it.

4. Tesla

Founded in 2003 and headquartered in Austin, Texas, Tesla (NASDAQ:TSLA) deals in fully electric vehicles and energy generation and storage systems. Kolokotrones owns over 3.4 million shares of Tesla at an estimated average price of $26.54. These shares have a market value of more than $3.7 billion and account for 2.80% of Kolokotrones’ portfolio. Kolokotrones has owned Tesla shares since Q2 2011 and has recently sold some shares of it.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

3. Amgen

Founded in 1980 and headquartered in Thousand Oaks, Calif., Amgen (NASDAQ:AMGN) is a biotechnology company. Kolokotrones owns over 15.7 million shares of Amgen at an estimated average price of $59.37. These shares have a market value of more than $3.8 billion and account for 2.87% of Kolokotrones’ portfolio. Kolokotrones has owned Amgen shares since Q1 2001 and has recently sold some shares of it.

2. Microsoft

Founded in 1975 and headquartered in Redmond, Wash., this company develops and offers software, services, devices, and solutions. Kolokotrones owns over 15 million shares of Microsoft (NASDAQ:MSFT) at an estimated average price of $24.84. These shares have a market value of more than $4.8 billion and account for 3.64% of Kolokotrones’ portfolio. Kolokotrones has owned Microsoft shares since Q1 2001 and has recently sold some shares of it.

1. Eli Lily & Co

Founded in 1876 and headquartered in Indianapolis, Ind., Eli Lilly (NYSE:LLY) develops and sells pharmaceutical products. Kolokotrones owns over 28 million shares of Eli Lilly at an estimated average price of $54.96. These shares have a market value of more than $8 billion and account for 6.24% of Kolokotrones’ portfolio. Kolokotrones has owned Eli Lilly shares since Q1 2001 and has recently sold some shares of it.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.